AJ Vaccines A/S: Financial statements 2024
CVR: 37911143
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 412,969,000 and a net result of DKK -807,117,000 compared with DKK -242,974,000 the year before. That is a decrease of 11.9% compared with the year before. The profit margin was -195.4%. Equity in the 2024 report amounted to DKK 501,919,000. The solvency ratio was 46.1%. The company had 581 employees in the financial year.
- Revenue
- DKK 412,969,000
- Gross Profit
- DKK -587,049,000
- Profit/Loss
- DKK -807,117,000
- Equity
- DKK 501,919,000
- Total Assets
- DKK 1,088,929,000
- Employees
- 581
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 413M | -587M | -807.1M | 501.9M | 581 |
| 2023 | 468.9M | -30.7M | -243M | 1B | 577 |
| 2022 | 421M | -66M | -268.1M | 994.7M | 556 |
| 2021 | 351.9M | -304M | -486.4M | 815.9M | 558 |
| 2020 | 351.6M | -313.9M | -450.2M | 1.1B | 702 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 23, 2024, Tarek Sherif Ahmed Abbas Hegazy has joined the board of directors of AJ Vaccines A/S.
As of July 23, 2024, Shan-E-Abbas Ashary has left the board of directors of AJ Vaccines A/S.
AJ Vaccines A/S has published its annual report for 2023. Revenue came to DKK 468,886,000, and the net result was DKK -242,974,000.
About AJ Vaccines A/S
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
